Outpatients

9 drugs in development·8 companies·1 clinical trial

Drug Pipeline by Phase

Approved(9)

Drug	Company
atomoxetine	SUNSET ISLAND GROUP (SUN)
atomoxetine	Aptinyx Inc. (APTX)
atomoxetine	Teva Pharmaceutical Industries Limited (TEVA)
atomoxetine	DR REDDYS LABORATORIES LTD (RDY)
bupropion	Prestige Consumer Healthcare Inc. (PBH)
bupropion	Design Therapeutics, Inc. (DSGN)
buspirone	OXFORD IMMUNOTEC GLOBAL PLC (OXFD)
trimipramine	ELITE PHARMACEUTICALS INC /NV/ (ELTP)
venlafaxine	Teva Pharmaceutical Industries Limited (TEVA)

BioSniper tracks 9 drugs in development for Outpatients across 8 companies.

There are 1 clinical trial targeting Outpatients tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.